The local medical community is excited with the introduction of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist showing remarkable results in scientific trials for addressing obesity. https://webcastlist.com/story23282819/retatrutide-australia-a-emerging-solution-for-weight-loss